These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7701559)

  • 1. Flexibility: the key to p53 function?
    Milner J
    Trends Biochem Sci; 1995 Feb; 20(2):49-51. PubMed ID: 7701559
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular perspective: p53 tumor suppressor.
    Goodsell DS
    Stem Cells; 1999; 17(3):189-90. PubMed ID: 10342561
    [No Abstract]   [Full Text] [Related]  

  • 3. Ironing out the angles in p53.
    Nat Struct Biol; 1995 Apr; 2(4):253-4. PubMed ID: 7796256
    [No Abstract]   [Full Text] [Related]  

  • 4. Interhelical angles in the solution structure of the oligomerization domain of p53: correction.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1995 Mar; 267(5203):1515-6. PubMed ID: 7878474
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural aspects of the p53 protein in relation to gene evolution: a second look.
    Soussi T; May P
    J Mol Biol; 1996 Aug; 260(5):623-37. PubMed ID: 8709143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the conformational diversity of cancer-associated mutations in p53 with ion-mobility mass spectrometry.
    Jurneczko E; Cruickshank F; Porrini M; Clarke DJ; Campuzano ID; Morris M; Nikolova PV; Barran PE
    Angew Chem Int Ed Engl; 2013 Apr; 52(16):4370-4. PubMed ID: 23494921
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
    Sakurai K; Schubert C; Kahne D
    J Am Chem Soc; 2006 Aug; 128(34):11000-1. PubMed ID: 16925398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [P53 at the atomic scale: the multiple faces of a crystal].
    Hainaut P
    Bull Cancer; 1997 Jul; 84(7):747-51. PubMed ID: 9339202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the human and worm p53 structures suggests a way for enhancing stability.
    Pan Y; Ma B; Levine AJ; Nussinov R
    Biochemistry; 2006 Mar; 45(12):3925-33. PubMed ID: 16548519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin.
    Taranta M; Bizzarri AR; Cannistraro S
    J Mol Recognit; 2009; 22(3):215-22. PubMed ID: 19140135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
    Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
    Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for "mutant conformation".
    Friedler A; DeDecker BS; Freund SM; Blair C; Rüdiger S; Fersht AR
    J Mol Biol; 2004 Feb; 336(1):187-96. PubMed ID: 14741214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substitutions G245C and G245D in the Zn(2+)-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain.
    Pintus SS; Ivanisenko NV; Demenkov PS; Ivanisenko TV; Ramachandran S; Kolchanov NA; Ivanisenko VA
    J Biomol Struct Dyn; 2013; 31(1):78-86. PubMed ID: 22803791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.
    Hainaut P; Milner J
    Cancer Res; 1993 Apr; 53(8):1739-42. PubMed ID: 8467489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70 interactions with the p53 tumour suppressor protein.
    Zylicz M; King FW; Wawrzynow A
    EMBO J; 2001 Sep; 20(17):4634-8. PubMed ID: 11532927
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure of the human p53 core domain in the absence of DNA.
    Wang Y; Rosengarth A; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-suppressor genes. X-rays strike p53 again.
    Vogelstein B; Kinzler KW
    Nature; 1994 Jul; 370(6486):174-5. PubMed ID: 8028656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.